Pharmacogenomics Testing

Leveraging the Power of Genomics to Improve Treatment Outcomes and Enhance Patient Care.

Header Image

down-icon

 

What is Pharmacogenomic Testing?

Pharmacogenomic testing, also known as pharmacogenetics or PGx testing, is a specialized type of genetic testing that examines how an individual’s genetic makeup influences their response to medications. It involves analyzing specific genes that play a role in drug metabolism, transport, and the body’s biological pathways related to drug effects. The goal of pharmacogenomic testing is to tailor medical treatment to an individual’s unique genetic profile, leading to safer and more effective medication regimens.

View the CDC’s Table of Pharmacogenomic Biomarkers in Drug Labeling


Visit Site

We Offer a Portfolio of Off-the-Shelf and Custom Genetic Services for the Following Partners:

icon

Clinical Trial Solutions

Learn More

icon

Employers

Learn More

icon

Medical Institutions

Learn More

icon

Physicians

Learn More

Incite Health Will Help You:

icon

Improve Patient Care and Outcomes

icon

Reduce Overall Costs Through Precision Medicine Applications

icon

Make Better and More Timely Clinical Decisions

Reports

This highly complex PGx data is distilled down into easy-to-review and interpretable reports with actionable recommendations for healthcare professionals. These detailed reports incorporate all CPIC guidelines. Here are examples of a Short Report and a Long Report:

John Doe Short Report

View Report
long report

John Doe Long Report

View Report

The Incite Advantage

Incite Health provides:

State-of-the-art pharmacogenomic technology and advanced data analysis capabilities.

Comprehensive and customizable pharmacogenomic testing panels.

Strong collaborations with leading genetic researchers and healthcare institutions.

Contact Us

Contact Us Button